These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22711881)

  • 1. Mitochondrial modulators for bipolar disorder: a pathophysiologically informed paradigm for new drug development.
    Nierenberg AA; Kansky C; Brennan BP; Shelton RC; Perlis R; Iosifescu DV
    Aust N Z J Psychiatry; 2013 Jan; 47(1):26-42. PubMed ID: 22711881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of mitochondrial dysfunction in bipolar disorder.
    Kato T
    Drug News Perspect; 2006 Dec; 19(10):597-602. PubMed ID: 17299601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A placebo-controlled trial of acetyl-L-carnitine and α-lipoic acid in the treatment of bipolar depression.
    Brennan BP; Jensen JE; Hudson JI; Coit CE; Beaulieu A; Pope HG; Renshaw PF; Cohen BM
    J Clin Psychopharmacol; 2013 Oct; 33(5):627-35. PubMed ID: 23948785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Mitochondrial Dysfunction for Bipolar Disorder.
    Kuperberg M; Greenebaum SLA; Nierenberg AA
    Curr Top Behav Neurosci; 2021; 48():61-99. PubMed ID: 33580439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial dysfunction in the pathophysiology of bipolar disorder: effects of pharmacotherapy.
    Callaly E; Walder K; Morris G; Maes M; Debnath M; Berk M
    Mini Rev Med Chem; 2015; 15(5):355-65. PubMed ID: 25807948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dysfunction as a critical event in the pathophysiology of bipolar disorder.
    Scaini G; Andrews T; Lima CNC; Benevenuto D; Streck EL; Quevedo J
    Mitochondrion; 2021 Mar; 57():23-36. PubMed ID: 33340709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurobiological basis of bipolar disorder: Mitochondrial dysfunction hypothesis and beyond.
    Kato T
    Schizophr Res; 2017 Sep; 187():62-66. PubMed ID: 27839913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders.
    Vawter MP; Tomita H; Meng F; Bolstad B; Li J; Evans S; Choudary P; Atz M; Shao L; Neal C; Walsh DM; Burmeister M; Speed T; Myers R; Jones EG; Watson SJ; Akil H; Bunney WE
    Mol Psychiatry; 2006 Jul; 11(7):615, 663-79. PubMed ID: 16636682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of mitochondrial DNA in calcium signaling abnormality in bipolar disorder.
    Kato T
    Cell Calcium; 2008 Jul; 44(1):92-102. PubMed ID: 18177933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial Agents for Bipolar Disorder.
    Pereira C; Chavarria V; Vian J; Ashton MM; Berk M; Marx W; Dean OM
    Int J Neuropsychopharmacol; 2018 Jun; 21(6):550-569. PubMed ID: 29596661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial dysfunction and psychiatric disorders.
    Rezin GT; Amboni G; Zugno AI; Quevedo J; Streck EL
    Neurochem Res; 2009 Jun; 34(6):1021-9. PubMed ID: 18979198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice.
    Dean OM; van den Buuse M; Bush AI; Copolov DL; Ng F; Dodd S; Berk M
    Curr Med Chem; 2009; 16(23):2965-76. PubMed ID: 19689277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased oxidative stress in the mitochondria isolated from lymphocytes of bipolar disorder patients during depressive episodes.
    Valvassori SS; Bavaresco DV; Feier G; Cechinel-Recco K; Steckert AV; Varela RB; Borges C; Carvalho-Silva M; Gomes LM; Streck EL; Quevedo J
    Psychiatry Res; 2018 Jun; 264():192-201. PubMed ID: 29653348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression.
    Toniolo RA; Silva M; Fernandes FBF; Amaral JAMS; Dias RDS; Lafer B
    J Neural Transm (Vienna); 2018 Feb; 125(2):247-257. PubMed ID: 29177955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mitochondrial dysfunction in bipolar disorder].
    Kato T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Apr; 25(2):61-72. PubMed ID: 16220655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain metabolic alterations in medication-free patients with bipolar disorder.
    Dager SR; Friedman SD; Parow A; Demopulos C; Stoll AL; Lyoo IK; Dunner DL; Renshaw PF
    Arch Gen Psychiatry; 2004 May; 61(5):450-8. PubMed ID: 15123489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depression.
    Dean OM; Turner A; Malhi GS; Ng C; Cotton SM; Dodd S; Sarris J; Samuni Y; Tanious M; Dowling N; Waterdrinker A; Smith D; Berk M
    Braz J Psychiatry; 2015; 37(1):3-12. PubMed ID: 25295681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pyruvate dehydrogenase complex disorder hypothesis for bipolar disorder.
    Campbell I; Campbell H
    Med Hypotheses; 2019 Sep; 130():109263. PubMed ID: 31383331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial DNA variation and increased oxidative damage in euthymic patients with bipolar disorder.
    Chang CC; Jou SH; Lin TT; Liu CS
    Psychiatry Clin Neurosci; 2014 Jul; 68(7):551-7. PubMed ID: 24447331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.